Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.50 |
| ▸ | SMPD2 | O60906 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | PPARA | Q07869 | 4/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.40 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL173510 | 1.00 | SIGMAR1 (0.50) | SIGMAR1SMPD2SLC6A2SLC6A4NR4A1 | |
| SCHEMBL7366363 | 1.00 | SIGMAR1 (0.50) | SIGMAR1SMPD2SLC6A2SLC6A4NR4A1 | |
| SCHEMBL29643326 | 1.00 | SIGMAR1 (0.50) | SIGMAR1SMPD2SLC6A2SLC6A4NR4A1 | |
| SCHEMBL173511 | 1.00 | SIGMAR1 (0.50) | SIGMAR1SMPD2SLC6A2SLC6A4NR4A1 | |
| SCHEMBL8803002 | 0.85 | SIGMAR1 (0.49) | SIGMAR1SMPD2SLC6A2SLC6A4NCEH1 | |
| SCHEMBL7563347 | 0.83 | SMPD2 (0.49) | SIGMAR1SMPD2SLC6A2SLC6A4NR4A1 | |
| SCHEMBL29643295 | 0.83 | SIGMAR1 (0.50) | SIGMAR1SLC6A2SLC6A4NCEH1 | |
| SCHEMBL4082840 | 0.82 | SMPD2 (0.48) | SIGMAR1SMPD2NR4A1NR4A2NR4A3 | |
| SCHEMBL1697074 | 0.82 | SMPD2 (0.48) | SIGMAR1SMPD2NR4A1NR4A2NR4A3 | |
| Leucine SCHEMBL28593704 | 0.82 | SLC7A5 (0.40) | SIGMAR1SMPD2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119367342-A | CYP-eicosanoids analogs for treating or preventing diseases associated with neovascularization and/or inflammation | 奥迈科斯治疗公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-113121648-B | N-methyl cyclic pentapeptide compound and synthesis method and application thereof | 河北科技大学 | 2022-07-01 | — | — | CN | disclosed |